Heparin Elevates Circulating Soluble fms-Like Tyrosine Kinase-1 Immunoreactivity in Pregnant Women Receiving Anticoagulation Therapy | Zendy

Victor Rosenberg | Zendy; Irina A. Buhimschi | Zendy; Charles J. Lockwood | Zendy; Michael J. Paidas | Zendy; Antonette T. Dulay | Zendy; Wenda Ramma | Zendy; Sonya S. AbdelRazeq | Zendy; Guomao Zhao | Zendy; Shakil Ahmad | Zendy; Asif Ahmed | Zendy; Catalin S. Buhimschi | Zendy

Open Access

Heparin Elevates Circulating Soluble fms-Like Tyrosine Kinase-1 Immunoreactivity in Pregnant Women Receiving Anticoagulation Therapy

Author(s) -

Victor Rosenberg,

Irina A. Buhimschi,

Charles J. Lockwood,

Michael J. Paidas,

Antonette T. Dulay,

Wenda Ramma,

Sonya S. AbdelRazeq,

Guomao Zhao,

Shakil Ahmad,

Asif Ahmed,

Catalin S. Buhimschi

Publication year - 2011

Publication title -

circulation

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 7.795

H-Index - 607

eISSN - 1524-4539

pISSN - 0009-7322

DOI - 10.1161/circulationaha.111.046821

Subject(s) - medicine , soluble fms like tyrosine kinase 1 , placental growth factor , heparin , preeclampsia , endocrinology , angiogenesis , placenta , tyrosine kinase , vascular endothelial growth factor , fetus , andrology , pregnancy , receptor , biology , genetics , vegf receptors

Alterations in circulating levels of pro- and antiangiogenic factors have been associated with adverse pregnancy outcomes. Heparin is routinely administered to pregnant women, but without clear knowledge of its impact on these factors.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research